Harmony Biosciences Holdings (HRMY) EBIT (QoQ) (2019 - 2026)
Harmony Biosciences Holdings (HRMY) EBIT (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Harmony Biosciences Holdings | 2.08 Bn | 1.55 Bn | 170.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.28% |
| Dec 31, 2025 | -41.12% |
| Sep 30, 2025 | 35.92% |
| Jun 30, 2025 | -14.34% |
| Mar 31, 2025 | 0.93% |
| Dec 31, 2024 | -9.70% |
| Sep 30, 2024 | 188.96% |
| Jun 30, 2024 | -58.96% |
| Mar 31, 2024 | 29.45% |
| Dec 31, 2023 | -37.69% |
| Sep 30, 2023 | 37.54% |
| Jun 30, 2023 | 16.03% |
| Mar 31, 2023 | -15.10% |
| Dec 31, 2022 | 300.08% |
| Sep 30, 2022 | -64.06% |
| Jun 30, 2022 | 20.18% |
| Mar 31, 2022 | -3.75% |
| Dec 31, 2021 | 35.99% |
| Sep 30, 2021 | -9.69% |
| Jun 30, 2021 | 60.41% |